Literature DB >> 23817163

Intranasal insulin to treat and protect against posttraumatic stress disorder.

William H Frey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23817163     DOI： 10.1097/NMD.0b013e318298302e

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN： 0022-3018            Impact factor:   2.254


× No keyword cloud information.
  4 in total

1.  Effect of administration method, animal weight and age on the intranasal delivery of drugs to the brain.

Authors:  Jishnu K S Krishnan; Peethambaran Arun; Bhadra Chembukave; Abhilash P Appu; Nivetha Vijayakumar; John R Moffett; Narayanan Puthillathu; Aryan M A Namboodiri
Journal:  J Neurosci Methods       Date:  2017-05-10       Impact factor: 2.390

2.  Rapid intranasal delivery of chloramphenicol acetyltransferase in the active form to different brain regions as a model for enzyme therapy in the CNS.

Authors:  Abhilash P Appu; Peethambaran Arun; Jishnu K S Krishnan; John R Moffett; Aryan M A Namboodiri
Journal:  J Neurosci Methods       Date:  2015-12-10       Impact factor: 2.390

Review 3.  Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.

Authors:  Alexander O Shpakov; Kira V Derkach; Lev M Berstein
Journal:  Future Sci OA       Date:  2015-11-01

Review 4.  Intranasal Insulin: a Treatment Strategy for Addiction.

Authors:  Bhavani Kashyap; Leah R Hanson; William H Frey Ii
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.